Literature DB >> 12671950

SCA2 may present as levodopa-responsive parkinsonism.

Haydeh Payami1, John Nutt, Steven Gancher, Thomas Bird, Melissa Gonzales McNeal, William K Seltzer, Jennifer Hussey, Paul Lockhart, Katrina Gwinn-Hardy, Amanda A Singleton, Andrew B Singleton, John Hardy, Matthew Farrer.   

Abstract

Some kindreds with familial parkinsonism exhibit genetic anticipation, suggesting possible involvement of trinucleotide repeat expansion. Recent reports have shown trinucleotide repeat expansions in the spinocerebellar ataxia 2 (SCA2) gene in patients with levodopa-responsive parkinsonism. We tested 136 unrelated patients with familial parkinsonism for SCA2 mutations. Two probands had borderline mutations; the rest were normal. (<or=31 repeats is normal, 32-35 is borderline, >or=36 is pathogenic). The expanded allele segregated with neurological signs in one kindred. The absence of borderline mutations in the normal population, and the co-segregation of the expanded allele with neurological signs in one kindred suggest that SCA2 mutations may be responsible for a subset of familial parkinsonism. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671950     DOI: 10.1002/mds.10375

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

1.  The influence of parental age and gender on anticipation in familial B-cell malignancies.

Authors:  Doru T Alexandrescu; Peter H Wiernik
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Magnetic resonance imaging in spinocerebellar ataxias.

Authors:  Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.

Authors:  Jorge Sequeiros; Sara Seneca; Joanne Martindale
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

4.  Heritability of Parkinson disease in Swedish twins: a longitudinal study.

Authors:  Karin Wirdefeldt; Margaret Gatz; Chandra A Reynolds; Carol A Prescott; Nancy L Pedersen
Journal:  Neurobiol Aging       Date:  2011-04-11       Impact factor: 4.673

5.  Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications.

Authors:  José Miguel Laffita-Mesa; Peter O Bauer; Vivian Kourí; Leodani Peña Serrano; Jane Roskams; Dennis Almaguer Gotay; Julio Cesar Montes Brown; Pedro Ariel Martínez Rodríguez; Yanetza González-Zaldívar; Luís Almaguer Mederos; Dany Cuello-Almarales; Jorge Aguiar Santiago
Journal:  Hum Genet       Date:  2011-10-30       Impact factor: 4.132

6.  Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

Authors:  Kai-Hsiang Chen; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  BMJ Case Rep       Date:  2012-03-20

7.  ATXN-2 CAG repeat expansions are interrupted in ALS patients.

Authors:  Lucia Corrado; Letizia Mazzini; Gaia Donata Oggioni; Bernadetta Luciano; Michela Godi; Alfredo Brusco; Sandra D'Alfonso
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

8.  Transcranial sonography in spinocerebellar ataxia type 2.

Authors:  Milija Mijajlović; Natasa Dragasević; Elka Stefanova; Igor Petrović; Marina Svetel; Vladimir S Kostić
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

Review 9.  Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

Authors:  Malco Rossi; Santiago Perez-Lloret; Daniel Cerquetti; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2014-06-06

Review 10.  Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.

Authors:  Michael A van Es; Helenius J Schelhaas; Paul W J van Vught; Nicola Ticozzi; Peter M Andersen; Ewout J N Groen; Claudia Schulte; Hylke M Blauw; Max Koppers; Frank P Diekstra; Katsumi Fumoto; Ashley Lyn LeClerc; Pamela Keagle; Bastiaan R Bloem; Hans Scheffer; Bart F L van Nuenen; Marka van Blitterswijk; Wouter van Rheenen; Anne-Marie Wills; Patrick P Lowe; Guo-fu Hu; Wenhao Yu; Hiroko Kishikawa; David Wu; Rebecca D Folkerth; Claudio Mariani; Stefano Goldwurm; Gianni Pezzoli; Philip Van Damme; Robin Lemmens; Caroline Dahlberg; Anna Birve; Rubén Fernández-Santiago; Stefan Waibel; Christine Klein; Markus Weber; Anneke J van der Kooi; Marianne de Visser; Dagmar Verbaan; Jacobus J van Hilten; Peter Heutink; Eric A M Hennekam; Edwin Cuppen; Daniela Berg; Robert H Brown; Vincenzo Silani; Thomas Gasser; Albert C Ludolph; Wim Robberecht; Roel A Ophoff; Jan H Veldink; R Jeroen Pasterkamp; Paul I W de Bakker; John E Landers; Bart P van de Warrenburg; Leonard H van den Berg
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.